Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention.

Nusca, Annunziata; Tuccinardi, Dario; Proscia, Claudio; Melfi, Rosetta; Manfrini, Silvia; Nicolucci, Antonio; Ceriello, Antonio; Pozzilli, Paolo; Ussia, Gian Paolo; Grigioni, Francesco; Di Sciascio, Germano

Nusca, Annunziata; Tuccinardi, Dario; Proscia, Claudio; Melfi, Rosetta; Manfrini, Silvia; Nicolucci, Antonio; Ceriello, Antonio; Pozzilli, Paolo; Ussia, Gian Paolo; Grigioni, Francesco; Di Sciascio, Germano.

Affiliation

Nusca A; Unit of Cardiac Sciences, Campus Bio-Medico University of Rome, Rome, Italy. a.nusca@unicampus.it.
Tuccinardi D; Unit of Endocrinology and Diabetes Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy.
Proscia C; Cardiology Department, Liverpool Heart and Chest Hospital NHS Trust, Liverpool, UK.
Melfi R; Unit of Cardiac Sciences, Campus Bio-Medico University of Rome, Rome, Italy.
Manfrini S; Unit of Endocrinology and Diabetes Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy.
Nicolucci A; Cardiovascular and Diabetes Department, IRCCS MultiMedica, Sesto San Giovanni, MI, Italy.
Ceriello A; Cardiovascular and Diabetes Department, IRCCS MultiMedica, Sesto San Giovanni, MI, Italy.
Pozzilli P; Unit of Endocrinology and Diabetes Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy.
Ussia GP; Unit of Cardiac Sciences, Campus Bio-Medico University of Rome, Rome, Italy.
Grigioni F; Unit of Cardiac Sciences, Campus Bio-Medico University of Rome, Rome, Italy.
Di Sciascio G; Unit of Cardiac Sciences, Campus Bio-Medico University of Rome, Rome, Italy.

Cardiovasc Diabetol ; 18(1): 147, 2019 11 09.

Article in En | MEDLINE | ID: mdl-31706305

Subject(s)

Blood Glucose/metabolism; Blood Platelets/drug effects; Clopidogrel/therapeutic use; Coronary Artery Disease/therapy; Diabetes Mellitus, Type 2/blood; Glycated Hemoglobin/metabolism; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors/therapeutic use; Platelet Aggregation/drug effects; Purinergic P2Y Receptor Antagonists/therapeutic use; Aged; Biomarkers/blood; Blood Glucose/drug effects; Blood Platelets/metabolism; Clopidogrel/adverse effects; Coronary Artery Disease/blood; Coronary Artery Disease/complications; Coronary Artery Disease/diagnosis; Coronary Thrombosis/etiology; Coronary Thrombosis/prevention & control; Diabetes Mellitus, Type 2/complications; Diabetes Mellitus, Type 2/diagnosis; Diabetes Mellitus, Type 2/drug therapy; Female; Humans; Hypoglycemic Agents/therapeutic use; Male; Middle Aged; Percutaneous Coronary Intervention/adverse effects; Platelet Aggregation Inhibitors/adverse effects; Prospective Studies; Purinergic P2Y Receptor Antagonists/adverse effects; Receptors, Purinergic P2Y12/blood; Receptors, Purinergic P2Y12/drug effects; Risk Assessment; Risk Factors; Treatment Outcome

Key words

Continuous glucose monitoring; Glycaemic variability; Glycated haemoglobin; Percutaneous coronary intervention; Platelet reactivity

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Blood Platelets / Coronary Artery Disease / Glycated Hemoglobin / Platelet Aggregation Inhibitors / Platelet Aggregation / Diabetes Mellitus, Type 2 / Purinergic P2Y Receptor Antagonists / Percutaneous Coronary Intervention / Clopidogrel Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cardiovasc Diabetol Journal subject: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Year: 2019 Document type: Article Affiliation country: Italy Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google